These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1981258)

  • 1. Serenics, serotonin and aggression.
    Olivier B; Mos J
    Prog Clin Biol Res; 1990; 361():203-30. PubMed ID: 1981258
    [No Abstract]   [Full Text] [Related]  

  • 2. A perspective: psychopharmacological aspects of aggression in animals and man.
    Singhal RL; Telner JI
    Psychiatr J Univ Ott; 1983 Sep; 8(3):145-53. PubMed ID: 6139834
    [No Abstract]   [Full Text] [Related]  

  • 3. [Animal models of aggression and serotonin receptor subtypes].
    Uemura N; Morimasa T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):1-8. PubMed ID: 7914039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two animal models of anxiety--different sensitivity for anxiolytic action of GABAA receptor complex ligands.
    Nazar M; Płaznik A; Jessa M
    Acta Physiol Hung; 1996; 84(4):437-9. PubMed ID: 9328625
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic receptors. Relevance to psychotropic drug action in man.
    Meltzer HY
    Ann N Y Acad Sci; 1990; 604():353-71. PubMed ID: 1977354
    [No Abstract]   [Full Text] [Related]  

  • 7. [5 HT2 antagonists and carpipramine].
    Sechter D; Loo H
    Rev Prat; 1990 Nov; 40(25):2363-5. PubMed ID: 2124722
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of 5-HT1 and 5-HT2 serotonin receptor agonists and antagonists on predator aggression in wild Norway rats].
    Popova NK; Nikulina EM; Shigantsov SN; Pliusnina IF; Amstislavskaia TG
    Biull Eksp Biol Med; 1996 Jun; 121(6):687-9. PubMed ID: 9035768
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible clinical applications of serenics and some implications of their preclinical profile for their clinical use in psychiatric disorders.
    Rasmussen DL; Olivier B; Raghoebar M; Mos J
    Drug Metabol Drug Interact; 1990; 8(1-2):159-86. PubMed ID: 2091889
    [No Abstract]   [Full Text] [Related]  

  • 10. Central serotonergic system and mechanism of anxiolytic action.
    Plaznik A; Stefański R; Jessa M; Nazar M; Bidziński A
    Acta Physiol Hung; 1996; 84(4):449-51. PubMed ID: 9328628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serenics. A new drug group with specific anti-aggressive effect].
    Wasielewski S
    Med Monatsschr Pharm; 1991 Oct; 14(10):290-1. PubMed ID: 1956352
    [No Abstract]   [Full Text] [Related]  

  • 12. Serenics.
    Olivier B; Mos J; Raghoebar M; de Koning P; Mak M
    Prog Drug Res; 1994; 42():167-308. PubMed ID: 8085010
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacological treatment of aggression and violence in the substance using population.
    Lavine R
    J Psychoactive Drugs; 1997; 29(4):321-9. PubMed ID: 9460025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ethologico-pharmacologic analysis of the psychotropic properties of phenylpiperazine derivatives in experimental models of aggressive behavior].
    Kosenkova NS; Butoma BG; Poshivalov VP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):564-6. PubMed ID: 2800706
    [No Abstract]   [Full Text] [Related]  

  • 15. CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties.
    Sills MA; Bennett DA; Lovell RA; Liebman JM; Wood PL; Glaeser BS; Williams M; Hutchison AJ
    Prog Clin Biol Res; 1990; 361():469-75. PubMed ID: 1981265
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex effects in defensive behavior: baseline differences and drug interactions.
    Blanchard DC; Shepherd JK; De Padua Carobrez A; Blanchard RJ
    Neurosci Biobehav Rev; 1991; 15(4):461-8. PubMed ID: 1686485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin and behavior: a brief summary.
    Aprison MH; Hingtgen JN
    Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status of the activity of 5-HT3 receptor antagonists in animal pharmacology].
    Raynaud G
    Ann Pharm Fr; 1995; 53(1):19-23. PubMed ID: 7741422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dopamine and serotonin. Involvement in the central effects of psychotropic agents].
    Hamon M
    Encephale; 1989; 15 Spec No():119-25. PubMed ID: 2663442
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of an anabolic androgenic steroid and low serotonin on social and non-social behaviors in male rats.
    Kubala KH; McGinnis MY; Anderson GM; Lumia AR
    Brain Res; 2008 Sep; 1232():21-9. PubMed ID: 18692488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.